FDA Application
-
NDC Search Results on Active Ingredient: aspirin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-50 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-33 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-03 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-02 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-07 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-08 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DIPHENHYDRAMINE CITRATE; CAFFEINE; ASPIRIN | 0067-8148-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-07 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-94 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-24 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-8203-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-30 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-07 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-06 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-06 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-05 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-8203-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-07 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-24 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-09 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-09 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-10 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2003-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-50 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
-